Izabela Kawczynski hired as Project Manager.
Reven selects a United States based CMO to handle drug GMP drug manufacturing and development.
Phase 1 protocol approved by the IRB giving Reven the green light for their Phase 1 study in San Antonio.
Reven Hires Vincent Vanderbent. Vincent Vanderbent hired as Reven’s Director of Corporate Communications.
Dr. Scott E. Woodman joins Reven's Advisory Board Click Here for CV - SCOTT_WOODMAN_CV_05_06_2018
Reven Selects CRO for Phase 1 study in United States.
Reven received approval for first patent allowance in Japan.
Reven received approval for first patent allowance in China.
Dr. William A. Gray joins Medical Advisory Board. Click here for CV - DrWilliamGray
Dr. Joshua A. Beckman joins Reven's Medical Advisory Board. Click here for CV - DrJoshuaBeckman